Stock 600993 MAYINGLONG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Mayinglong Pharmaceutical Group Co., LTD.

Equities

600993

CNE000001HN2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
28.82 CNY -0.62% Intraday chart for Mayinglong Pharmaceutical Group Co., LTD. +3.52% +19.19%
Apr. 19 Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment MT

Business Summary

Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.

Number of employees: 2,882

Sales per Business

CNY in Million2022Weight2023Weight Delta
Hemorrhoid Products
41.2 %
1,488 42.1 % 1,292 41.2 % -13.18%
Pharmaceutical
34.7 %
1,354 38.3 % 1,088 34.7 % -19.67%
Other Products
17.3 %
585 16.6 % 542 17.3 % -7.31%
Medical Services
11.0 %
259 7.3 % 345 11.0 % +33.28%
Internal Offset
-5.4 %
-189 -5.3 % -168 -5.4 % -10.76%
Other Business
1.2 %
35 1.0 % 38 1.2 % +9.08%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.9 %
3,530 99.9 % 3,133 99.9 % -11.26%
International
0.1 %
2 0.1 % 4 0.1 % +74.71%

Managers

Managers TitleAgeSince
You Zhang Xia CEO
 Chief Executive Officer 46 -
Bing Wang DFI
 Director of Finance/CFO 42 19-05-27
Li De Wang CHM
 Chairman 59 -
Ping An Liu BRD
 Director/Board Member 38 21-08-18
Zhong Hua Zhao IRC
 Investor Relations Contact - -
Qian Ma SEC
 Corporate Secretary 43 -

Members of the board

Members of the board TitleAgeSince
You Zhang Xia CEO
 Chief Executive Officer 46 -
Li De Wang CHM
 Chairman 59 -
Qi Long Huang BRD
 Director/Board Member 60 23-06-12
Biao Xu BRD
 Director/Board Member 48 22-06-13
Ping An Liu BRD
 Director/Board Member 38 21-08-18
Peng Mao BRD
 Director/Board Member 42 19-05-27
Jun Qi BRD
 Director/Board Member 42 22-06-13
Yong Hui Zhang BRD
 Director/Board Member 52 22-06-13
Ye Xiang Xie BRD
 Director/Board Member 58 19-05-27
Qi Ye BRD
 Director/Board Member 57 21-05-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 431,053,891 270,120,360 ( 62.67 %) 0 62.67 %

Shareholders

NameEquities%Valuation
CHINA BAOAN GROUP CO., LTD.
30.19 %
129,918,181 30.19 % 399 M ¥
Wuhan State Owned Assets Sup. & Adm. Commssion
5.217 %
22,449,723 5.217 % 69 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
2.949 %
12,690,622 2.949 % 39 M ¥
Fu An Zhao
1.698 %
7,308,027 1.698 % 22 M ¥
Citic Securities Co., Ltd. (Invt Port)
1.230 %
5,290,800 1.230 % 16 M ¥
Zhong Ou Asset Management Co., Ltd
0.9349 %
4,022,757 0.9349 % 12 M ¥
China Southern Asset Management Co., Ltd.
0.7081 %
3,047,103 0.7081 % 9 M ¥
First-Trust Fund Management Co., Ltd.
0.6890 %
2,965,000 0.6890 % 9 M ¥
China Asset Management Co., Ltd.
0.6525 %
2,807,709 0.6525 % 9 M ¥
Caitong Securities Asset Management Co., Ltd.
0.5810 %
2,500,000 0.5810 % 8 M ¥

Company contact information

Mayinglong Pharmaceutical Group Co., Ltd.

No. 100 Zhoujiawan South Lake

430064, Wuhan

+

http://www.mayinglong.cn
address Mayinglong Pharmaceutical Group Co., LTD.(600993)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
MAYINGLONG PHARMACEUTICAL GROUP CO., LTD. Stock Mayinglong Pharmaceutical Group Co., LTD.
+19.19% 1.73B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.83% 43.57B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+21.29% 22.7B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.41% 14.32B
CIPLA LIMITED Stock Cipla Limited
+11.11% 13.42B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.91% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-6.84% 6.98B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.41% 5.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600993 Stock
  4. Company Mayinglong Pharmaceutical Group Co., LTD.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW